Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
797.09
+13.44 (+1.72%)
Streaming Delayed Price
Updated: 9:59 AM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
76,081
Open
788.92
Bid (Size)
795.82 (40)
Ask (Size)
797.09 (40)
Prev. Close
783.65
Today's Range
785.00 - 799.00
52wk Range
476.49 - 821.11
Shares Outstanding
91,779,465
Dividend Yield
0.44%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Regeneron Announces Investor Conference Presentations
February 11, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI, Showcasing Novel Approaches to Treating Allergy
February 10, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Performance
YTD
+2.7%
+2.7%
1 Month
+5.0%
+5.0%
3 Month
+14.7%
+14.7%
6 Month
+40.8%
+40.8%
1 Year
+20.1%
+20.1%
More News
Read More
The Great Reversal: Tariffs Ignite Goods Inflation as Services Cool in Latest PCE Data
February 06, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Regeneron Stock Slips Premarket Even After Wall Street Lifts Targets On Strong Q4 — What’s Weighing On The Stock?
↗
February 02, 2026
Via
Stocktwits
Regeneron Pharmaceuticals (NASDAQ:REGN) Reports Q4 2025 Earnings Beat Amid Product Transition
↗
January 30, 2026
Via
Chartmill
Topics
Earnings
Regeneron (REGN) Q1 2025 Earnings Call Transcript
↗
February 05, 2026
Via
The Motley Fool
Topics
Earnings
Supply Chain
Regeneron (REGN) Q2 2025 Earnings Call Transcript
↗
February 05, 2026
Via
The Motley Fool
Topics
Earnings
Regeneron (REGN) Q4 2024 Earnings Call Transcript
↗
February 05, 2026
Via
The Motley Fool
Topics
Earnings
Regeneron (REGN) Q3 2024 Earnings Call Transcript
↗
February 05, 2026
Via
The Motley Fool
Topics
Earnings
EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases
February 02, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
This $24 Million Buy Amid a 45% Stock Drop Signals Conviction in a High-Margin Data Business
↗
January 30, 2026
Via
The Motley Fool
Regeneron (REGN) Q4 2025 Earnings Call Transcript
↗
January 30, 2026
Via
The Motley Fool
Topics
Earnings
These S&P500 stocks that are showing activity before the opening bell on Friday.
↗
January 30, 2026
Via
Chartmill
Regeneron’s New Growth Engine Is Starting To Show – But Core Eylea Weakness Weighs On REGN Stock
↗
January 30, 2026
Via
Stocktwits
Regeneron (NASDAQ:REGN) Posts Better-Than-Expected Sales In Q4 CY2025
January 30, 2026
Via
StockStory
Regeneron Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
January 30, 2026
From
Regeneron Pharmaceuticals, Inc.
Via
GlobeNewswire
Earnings To Watch: Regeneron (REGN) Reports Q4 Results Tomorrow
January 28, 2026
Via
StockStory
Topics
Artificial Intelligence
2 Healthcare Stocks Poised for a Comeback in 2026
↗
January 22, 2026
Via
The Motley Fool
GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
January 20, 2026
Via
MarketMinute
Topics
Intellectual Property
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All
↗
January 19, 2026
Via
MarketBeat
Topics
ETFs
3 Profitable Stocks We Think Twice About
January 18, 2026
Via
StockStory
1 Mooning Stock with Exciting Potential and 2 Facing Headwinds
January 12, 2026
Via
StockStory
Topics
Economy
Energy
Regeneron Just Moved From Underperform To Buy - Here's Why
↗
January 07, 2026
Via
Benzinga
These S&P500 stocks are moving in today's session
↗
January 07, 2026
Via
Chartmill
Why Regeneron (REGN) Stock Is Trading Up Today
January 07, 2026
Via
StockStory
Topics
Artificial Intelligence
Frequently Asked Questions
Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 797.09
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 02/13/26 09:59 AM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 73.16B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 73B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
